Non-invasive biomarkers for monitoring the fibrogenic process in liver:A short survey

查看全文 作　　者：Axel M [1]Gressner;Chun-Fang [2]Gao;Olav A [1]Gressner

机构地区：[1]Institute of Clinical Chemistry and Pathobiochemistry, Central Laboratory, RWTH- University Hospital Aachen, Pauwelsstr. 30, 52074 Aachen, Germany;[2]Department of Laboratory Medicine, Eastern Hepatobiliary Hospital, Second Military Medical University, 225 Shanghai Road, Shanghai 200438, China

出　　处：《World Journal of Gastroenterology》索引2009年第15卷第20期,共8页

摘　　要：The clinical course ofchronic liver diseases is significantly dependent on the progression rate and the extent offibrosis, i.e. the non-structured replacement of necrotic parenchyma by extracellular matrix. Fibrogenesis, i.e. the development offibrosis can be regarded as an unlimited wound healing process, which is based on matrix (connective tissue) synthesis in activated hepatic stellate cells, fibroblasts (fibrocytes), hepatocytes and biliary epithelial cells, which are converted to matrix-producing (myo-)fibroblasts by a process defined as epithelial-mesenchymal transition. Blood (noninvasive) biomarkers offibrogenesis and fibrosis can be divided into class and class analytes. Class biomarkers are those single tests, which are based on the pathophysiology offibrosis, whereas class biomarkers aremostly multiparametric algorithms, which have been statistically evaluated with regard to the detection and activity ofongoing fibrosis. Currently available markers fulfil the criteria ofideal clinical-chemical tests only partially, but increased understanding ofthe complex pathogenesis offibrosis offers additional ways for pathophysiologically well based serum (plasma) biomarkers. They include TGF-β-driven marker proteins, bone marrow-derived cells (fibrocytes), and cytokines, which govern proand anti-fibrotic activities. Proteomic and glycomic approaches ofserum are under investigation to set up specific protein or carbohydrate profiles in patients with liver fibrosis. These and other novel parameters will supplement or eventually replaceliver biopsy/histology, high resolution imaging analysis, and elastography for the detection and monitoring of patients at risk ofdeveloping liver fibrosis. 关键词：生物标志物肝纤维化侵入性进程监测

相关文献

参考文献（42）
引证文献（6）
耦合文献（21）

参考文献(42)

引证文献(6)

耦合文献(21)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Non-invasive biomarkers for monitoring the fibrogenic process in liver:A short survey

参考文献(42)

引证文献(6)

耦合文献(21)

用户提示